Press Release

WASHINGTON (September 18, 2025) — Today, the Council for Innovation Promotion (C4IP) congratulated Director John Squires on his confirmation as the new Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (USPTO). Throughout his career, Director Squires has been a strong advocate for IP policies that promote research

WASHINGTON (September 18, 2025) — Today, the Council for Innovation Promotion (C4IP) launched www.I-MAKexposed.com, a new website to combat the patent misinformation spread by the Initiative for Medicines, Access, and Knowledge (I-MAK): Frank Cullen, Executive Director of the Council for Innovation Promotion, issued the following statement: “For too long, I-MAK has sought to undermine the

WASHINGTON (August 19, 2025) — Recently, Senators Maggie Hassan (D-NH) and Josh Hawley (R-MO) introduced the Medication Affordability and Patent Integrity Act, S. 2658, which would mandate that life sciences innovators submit extensive and often confidential information related to drug approval to the U.S. Patent and Trademark Office (USPTO). The bill would also require companies

Roundtable Highlights How Strong IP Protections Drive Breakthroughs and Benefit Patients RALEIGH, NC (August 12, 2025) — On Tuesday, August 26, from 10:00 AM to 11:00 AM ET, the Council for Innovation Promotion (C4IP) and We Work for Health (WWFH) will host a roundtable focused on the pivotal role intellectual property (IP) plays in advancing

WASHINGTON (August 11, 2025) — Today, Frank Cullen, executive director of the Council for Innovation Promotion, issued the following statement regarding the Department of Commerce’s letter to Harvard University regarding the ‘march-in’ process: “We are deeply troubled by the Commerce Department’s letter to Harvard University stating that the Department is ‘initiating the ‘march-in’ process under

WASHINGTON (August 5, 2025) — Senators Peter Welch (D-VT), Josh Hawley (R-MO), and Amy Klobuchar (D-MN) recently introduced the Eliminating Thickets to Increase Competition (ETHIC) Act, S. 2276, in the U.S. Senate. This legislation would prohibit patent holders, specifically in the pharmaceutical sector, from asserting more than one patent out of a certain defined group

WASHINGTON (August 4, 2025) — Today, the Council for Innovation Promotion (C4IP) applauds the European Commission’s decision to decisively withdraw its proposed regulations on standard essential patents (SEPs). The proposal risked undermining innovation in Europe, the United States, and elsewhere, as well as the current system of industry-led negotiations based on fair, reasonable, and nondiscriminatory

WASHINGTON (June 30, 2025) — The Senate has started its marathon voting session on the One Big Beautiful Bill Act, which currently includes a moratorium on state-level regulations of artificial intelligence technologies. Frank Cullen, executive director of the Council for Innovation Promotion (C4IP), released the following statement urging Congress to remove the moratorium from the

WASHINGTON (May 28, 2025) — Today, the Council for Innovation Promotion (C4IP) released its second annual Congressional Innovation Scorecard, offering a comprehensive assessment of how every member of Congress engages with policies that shape America’s innovation ecosystem. The Scorecard assigns each legislator a letter grade based on their record of supporting strong and effective intellectual